Point72 Asset Management »

Syros Pharmaceuticals shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Syros Pharmaceuticals (SYRS) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Syros Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syros Pharmaceuticals held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syros Pharmaceuticals by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 1.5M 7.79

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Dell Technologies CL C (DELL)
Union Pacific Corporation (UNP)
Boston Scientific Corporation (BSX)
Johnson Ctls Intl SHS (JCI)
NVIDIA Corporation (NVDA)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
CSX Corporation (CSX)
Honeywell International (HON)
Thermo Fisher Scientific (TMO)
Oracle Corporation (ORCL)
Western Digital (WDC)

View all positions for Point72 Asset Management

Top funds holding Syros Pharmaceuticals

Artal Group
Adage Capital Partners GP
Samsara BioCapital
Avidity Partners Management
Blue Owl Capital Holdings
Point72 Asset Management
Flagship Ventures Management
Vanguard Group
Kennedy Capital Management
Opaleye Management
Walleye Trading Advisors
BlackRock
Omega Fund Management
Goldman Sachs Group
Geode Capital Management

View all funds holding Syros Pharmaceuticals